Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2B
pubmed:dateCreated
2001-6-8
pubmed:abstractText
The efficacy and toxicity of the combination of two cytotoxic compounds that are active as single agents in non-small cell lung cancer (NSCLC), paclitaxel (Taxol) and carboplatin (Paraplatin) was investigated in a multicenter, community-based setting.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1487-94
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:11396237-Adenocarcinoma, pubmed-meshheading:11396237-Aged, pubmed-meshheading:11396237-Antineoplastic Agents, Phytogenic, pubmed-meshheading:11396237-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11396237-Carboplatin, pubmed-meshheading:11396237-Carcinoma, Large Cell, pubmed-meshheading:11396237-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:11396237-Carcinoma, Squamous Cell, pubmed-meshheading:11396237-Cohort Studies, pubmed-meshheading:11396237-Dose-Response Relationship, Drug, pubmed-meshheading:11396237-Female, pubmed-meshheading:11396237-Follow-Up Studies, pubmed-meshheading:11396237-Humans, pubmed-meshheading:11396237-Lung Neoplasms, pubmed-meshheading:11396237-Male, pubmed-meshheading:11396237-Middle Aged, pubmed-meshheading:11396237-Neoplasm Metastasis, pubmed-meshheading:11396237-Paclitaxel, pubmed-meshheading:11396237-Survival Rate, pubmed-meshheading:11396237-Time Factors, pubmed-meshheading:11396237-Treatment Outcome
pubmed:articleTitle
Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
pubmed:affiliation
Clinique du Sud-Luxembourg (Site St.-Joseph), Arlon, Belgium.
pubmed:publicationType
Journal Article, Clinical Trial, Multicenter Study